CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic Leukemia

Exclusion Criteria

• •Pregnant or lactating women; (female participants of reproductive potential must have a negative serum or urine pregnancy test);
• •Uncontrolled active infection, HIV infection, syphilis serology reaction positive;
• •Active hepatitis B or hepatitis C infection;
• •Recent or current use of glucocorticoid or other immunosuppressor;
• •With severe cardiac, liver, renal insufficiency, diabetes and other diseases;
• •Participate in other clinical research in the past three months;
• •previously treatment with any gene therapy products;
• •Researchers think of that does not fit to participate in the study, or other cases that affect the clinical trial results.